Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Elatki

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|May 25, 1999
[Dysthymic disorders]M Ferreri, P Morand, S Elatki, et al.
L'Encephale|June 20, 2000
[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes]H Lôo, M F Poirier, H Ollat, et al.
Psychopharmacology|October 1, 1996
Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized studyF Radat, I Berlin, O Spreux-Varoquaux, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|May 25, 1999
[Dysthymic disorders]M Ferreri, P Morand, S Elatki, et al.
L'Encephale|June 20, 2000
[Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes]H Lôo, M F Poirier, H Ollat, et al.
Psychopharmacology|October 1, 1996
Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized studyF Radat, I Berlin, O Spreux-Varoquaux, et al.
Pageof 1